Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 3, 2007 - Xanthus Pharmaceuticals, Inc today presented data demonstrating that Symadex(TM) reversed the clinical and pathological signs of chronic disease in an animal model for multiple sclerosis. The presentation was made by Stephen J. Karlik, Ph.D., Profess...Xanthus Presents Novel Approach for
Autoimmune Disease Reversal with Symadex ... presented data demonstrating that Symadex(TM) reversed the clinical and ... the same time, Symadex did not affect ...Xanthus Presents Preclinical Data Demonstrating
Potent Symadex Activity in Leukemia Cells ... presentation of data from preclinical studies in which Symadex(TM) ... previously identified Symadex as a potent ...Xanthus' Symadex Demonstrates Ability To Increase Spinal Cord ...
Xanthus Pharmaceuticals, Inc. presented preclinical data further supporting the potential for Symadex™ to reverse the clinical and pathological signs of multiple ...Xanthus' Symadex Reverses Disease In Preclinical Mouse Models Of ...
Xanthus Pharmaceuticals, Inc. presented data demonstrating that SymadexTM, a selective FLT3 inhibitor, acted to reverse disease in mouse models of both acute and ...Xanthus Pharmaceuticals, Inc.' Symadex Reverses Disease in Preclinical ...
Xanthus Pharmaceuticals, Inc.' Symadex Reverses Disease in Preclinical Mouse ... presented data demonstrating that SymadexTM, a selective FLT3 inhibitor, acted ...Xanthus' Symadex Reverses Disease in Preclinical Mouse Models of ...
Disaboom.com is a dynamic, interactive online resource for people with ... Xanthus' Symadex Reverses Disease in... Posted on: Thu, Apr 17 2008 6:51 AM ...